1h Free Analyst Time
The Biobanking Market grew from USD 70.33 billion in 2023 to USD 78.21 billion in 2024. It is expected to continue growing at a CAGR of 11.71%, reaching USD 152.75 billion by 2030. Speak directly to the analyst to clarify any post sales queries you may have.
Biobanking encompasses the collection, processing, storage, and distribution of biological samples and associated data for research and therapeutic purposes. The necessity of biobanking has surged with advancements in personalized medicine, genomics, and biotherapeutics, fueled by demands for comprehensive biological data repositories. Applications span from medical research to pharmaceutical development, enabling insights into disease mechanisms and drug development pipelines. Biobanks service various end-users, including hospitals, research organizations, and biopharmaceutical companies. Market growth is influenced by factors such as increasing prevalence of chronic diseases, technological innovations in genomics, and rising investments in R&D. The expanding focus on precision medicine and genomics paves pathways for potential opportunities, particularly with integrating artificial intelligence for robust data analytics and emerging markets demonstrating heightened interest in biobanking infrastructures. Recommendations include forging strategic partnerships with research institutes and utilizing blockchain technology to ensure data security and integrity, enhancing collaboration and trust among stakeholders.
Despite growth potential, challenges persist. Ethical concerns regarding informed consent, privacy, and data ownership could impede market expansion. High costs associated with biobank maintenance and a lack of standardization in sample handling and data curation create operational hurdles. Additionally, regulatory complexities and stringent compliance requirements can deter new entrants. Innovation should emphasize ethical frameworks to ensure participant data privacy, alongside developing cost-effective cryopreservation technologies and automated systems for sample processing. Research opportunities lie in exploring novel biomarkers and improving sample quality through standardized protocols. The market is characterized by rapid technological evolution, with incumbents investing in advanced bioinformatics and digital platforms to enhance data accessibility and utility. Market players should leverage strategic alliances and technological advancements to stay competitive. Overall, biobanking holds transformative potential for advancing healthcare research, but navigating ethical, operational, and technological challenges is crucial for sustained growth and maximizing the market's impact.
Understanding Market Dynamics in the Biobanking Market
The Biobanking Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.- Market Drivers
- Increasing burden of chronic diseases across economies and need for better healthcare infrastructure
- Growing private and public investments in pharmaceutical research
- Rising awareness and government initiatives in regenerative medicine
- Market Restraints
- Problems associated with procedure harmonization due to decentralized nature of biobanks
- Market Opportunities
- Ongoing research to improve and ensure standardization of data acquisition and analysis in biobanks
- Emerging focus on biobank sustainability and development of imaging biobanks
- Market Challenges
- Ethical and legal concerns associated with biobanking
Exploring Porter’s Five Forces for the Biobanking Market
Porter’s Five Forces framework further strengthens the insights of the Biobanking Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.Applying PESTLE Analysis to the Biobanking Market
External macro-environmental factors deeply influence the performance of the Biobanking Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.Analyzing Market Share in the Biobanking Market
The Biobanking Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.Evaluating Vendor Success with the FPNV Positioning Matrix in the Biobanking Market
The Biobanking Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.Strategic Recommendations for Success in the Biobanking Market
The Biobanking Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.Key Company Profiles
The report delves into recent significant developments in the Biobanking Market, highlighting leading vendors and their innovative profiles. These include AMS Biotechnology (Europe) Limited, ASKION GmbH, Avantor, Inc., Azenta Life Sciences, Bay Biosciences LLC, Becton, Dickinson and Company, BioIVT LLC, BioKryo by L’AIR LIQUIDE S.A., BocaBio, Charles River Laboratories International, Inc., Cryoport Systems, LLC, CTIBiotech, Cureline, Inc., Firalis Group, Greiner AG, Hamilton Company, Merck KgaA, Micronic Holding B.V., PHC Holdings Corporation, Promega Corporation, ProteoGenex, QIAGEN N.V., Sopachem NV/SA, SPT Labtech Ltd., STEMCELL Technologies Inc., Taylor-Wharton, Tecan Trading AG, Thermo Fisher Scientific Inc., UK Biobank Limited, and US Biolab Corporation, Inc..Market Segmentation & Coverage
This research report categorizes the Biobanking Market to forecast the revenues and analyze trends in each of the following sub-markets:- Product
- Consumables
- Equipment & Instruments
- Services
- Software
- Sample Type
- Biological Fluids
- Blood Products
- Cell Lines
- Human Tissues
- Nucleic Acids
- Storage Type
- Automated
- Manual
- Application
- Clinical Research
- Life Science Research
- Regenerative Medicine
- End-User
- Academic & Research Institutes
- Hospitals
- Pharmaceutical & Biotechnology
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
- Americas
The report provides a detailed overview of the market, exploring several key areas:
- Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
- Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
- Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
- Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
- Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.
Additionally, the report addresses key questions to assist stakeholders in making informed decisions:
- What is the current size of the market, and how is it expected to grow?
- Which products, segments, and regions present the most attractive investment opportunities?
- What are the prevailing technology trends and regulatory factors influencing the market?
- How do top vendors rank regarding market share and competitive positioning?
- What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?
Table of Contents
1. Preface
2. Research Methodology
4. Market Overview
5. Market Insights
6. Biobanking Market, by Product
7. Biobanking Market, by Sample Type
8. Biobanking Market, by Storage Type
9. Biobanking Market, by Application
10. Biobanking Market, by End-User
11. Americas Biobanking Market
12. Asia-Pacific Biobanking Market
13. Europe, Middle East & Africa Biobanking Market
14. Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
The leading players in the Biobanking Market, which are profiled in this report, include:- AMS Biotechnology (Europe) Limited
- ASKION GmbH
- Avantor, Inc.
- Azenta Life Sciences
- Bay Biosciences LLC
- Becton, Dickinson and Company
- BioIVT LLC
- BioKryo by L’AIR LIQUIDE S.A.
- BocaBio
- Charles River Laboratories International, Inc.
- Cryoport Systems, LLC
- CTIBiotech
- Cureline, Inc.
- Firalis Group
- Greiner AG
- Hamilton Company
- Merck KgaA
- Micronic Holding B.V.
- PHC Holdings Corporation
- Promega Corporation
- ProteoGenex
- QIAGEN N.V.
- Sopachem NV/SA
- SPT Labtech Ltd.
- STEMCELL Technologies Inc.
- Taylor-Wharton
- Tecan Trading AG
- Thermo Fisher Scientific Inc.
- UK Biobank Limited
- US Biolab Corporation, Inc.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 198 |
| Published | October 2024 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 78.21 Billion |
| Forecasted Market Value ( USD | $ 152.75 Billion |
| Compound Annual Growth Rate | 11.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 31 |
